---
draft: yes
title: Cardiac Safety from Preclinical to the Clinic â€“ Industry and Regulatory Trends
  in T-QT and Concentration-QT Studies for Assessing QT Prolongation Risks
author: ''
date: '2021-03-23T08:30:00-08:00'
slug: cardiac-safety-from-preclinical-to-the-clinic-industry-and-regulatory-trends-in-t-qt-and-concentration-qt-studies-for-assessing-qt-prolongation-risks
categories:
  - Clinical Trial
tags:
  - PBSS
  - TQT
  - cQT
type: webinar
url_register: ~
url_freeregister: https://www.pbss.org/aspx/eventInfo.aspx?eID=715
url_slides: ~
url_video: false
url_audio: ~
url_code: ~
url_pdf: ~
date_end: '2021-03-24T12:05:00-08:00'
all_day: yes
publishDate: '2021-03-10T17:46:36-08:00'
authors: []
featured: no
image:
  caption: ''
  focal_point: ''
  preview_only: no
slides: ''
projects: []
location: ~
address:
  street: ~
  city: ~
  region: ~
  postcode: ~
  country: ~
summary: ~
abstract: ~
speaker: "Borje Darpo (ERT) | Jay Mason (Spaulding Clinical) | Bela Patel (Merck) | Anne Bonneville (Terns Pharmaceuticals) | Lauren Lohmer (Nuventra) | Yehong Wang (Genentech)"
---
<!--more-->
**Symposium Agenda (All times are in Pacific Time)**  

**Day 1: March 23, 2021**   
<span style="color:grey">
*8:30-8:45am:* Introductions  
*8:45-9:30am:* State-of-the-Art: TQT studies (QT and C-QT Analyses, Challenges & Examples) - Borje Darpo (ERT)  
*9:30-10:15am:* Cardiac safety and TQT waivers (Types of studies - FIH, Food effect, DDI and timing, Issues with ECG collection) - Jay Mason (Spaulding)  
*10:15-10:25am:* Sponsor Presentation   
*10:25-10:40am:* Break  
*10:40-11:25am:* TBD  
*11:25am-12:10pm:* New opportunities for C-QT and C-QT in non-ideal scenarios - Lauren Lohmer (Nuventra)  
*12:10pm-12:40pm:* Panel Discussion  
</span>

**Day 2: March 24, 2021**  
<span style="color:grey">
*8:30-8:45am:* Introductions  
*8:45-9:30am:* Case Study - Biologics C-QT project supporting a major readout - Yehong Wang (Genentech)  
*9:30-10:15am:* TBD  
*10:15-10:25am:* Sponsor Presentation  
*10:25-10:40am:* Break  
*10:40-11:25am:* Non-clinical aspects related to the ICH Q&A - Anne Bonneville (Terns Pharmaceuticals)  
*11:25pm-12:05pm:* Panel Discussion 
</span>
